Routine prostate-cancer screening doesn’t save sufficient lives to justify exposing men to risks of death, incontinence and impotence, a U.S. panel said in a report drawing criticism from patient advocates.
A draft report, released today by the Health and Human Services Department’s Preventive Services Task Force, recommends against so-called PSA tests for men who don’t have symptoms that are “highly suspicious for prostate cancer.”
